LimmaTech Biologics Appoints Franz-Werner Haas as CEO to Lead Company into Next Stage of Corporate Growth

SCHLIEREN, Switzerland–(BUSINESS WIRE)–LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced the appointment of experienced biotechnology leader Franz-Werner Haas, LL.D., as its Chief Executive Officer. Dr. Haas joins LimmaTech after 11 years as an executive at CureVac SE, where he most recently served as CEO following his tenures as Chief Corporate Officer and Chief Operating Officer. With a remarkable ca

Recent Articles